NJ TECH CORNER: Tabula Rasa Healthcare, Inc.
Company Overview
Tabula Rasa Healthcare, Inc. (NASDAQ:TRHC) is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risks. Clients include at-risk healthcare organizations, primary Program for All-inclusive Care for the Elderly (PACE) organizations, managed-care organizations, post-acute care facilities, behavioral health organizations and other provider groups. Founded in 2011, the Moorestown-based company has a total workforce of more than 200 employees.
Investment & Financial Information
Shares of common stock outstanding (April 25, 2017): |
17,218,168
|
Share price of stock (Jan. 26, 2018 ) |
$35.86 |
Share price of stock (one year ago) |
$14.53 |
Current valuation (Jan, 26,2018) |
$617.44 million |
Valuation one year ago |
$241.61 million |
Stock Symbol: |
TRHC |
Revenues (as of 9 months ended Sept. 30, 2017)
|
$71.39 million |
Revenues (as of 9 months ended Sept. 30, 20160 |
$58.73 million |
Net Income(as of 9 months ended Sept. 30, 2017)
|
$3.35 million |
Net Income (Loss) (as of 9 months ended Sept. 30, 2016)
|
($219,000) |
Management Team
Name |
Age |
Title |
Dr. Calvin H. Knowlton |
67 |
Co-Founder, Chairman and CEO |
Dr. Orsula V. Knowlton |
49 |
Co-Founder and President |
Brian Adams |
36 |
Chief Financial Officer |
Board of Directors
Name |
Age |
Title |
Glenn Bressner |
56 |
Director, CareKinesis, Inc.*;Managing Partner, Originate Ventures and Mid-Atlantic Funds; Vice Chairman, Innovative Solutions and Support Inc.; Chairman of Audit Committee and Member, Board of Governors of St. Christopher’s Hospital for Children |
Daniel Lubin |
57 |
Director, CareKinesis, Inc.*; Managing Partner and Co-Founder, Radius Ventures, LLC |
Bruce Luehrs |
63 |
Director, CareKinesis, Inc.*; Managing Partner, Rittenhouse Ventures |
Dr. Dennis Helling |
68 |
Clinical Professor, University of Colorado Skaggs School of Pharmaceutical Sciences; Co-Founder and former President, American College of Clinical Pharmacy; Member of the Board, Care Synergy; Vice-Chairman, The Denver Hospice Board of Directors; Member, American Pharmacists Association Board of Trustees and Pharmacy Specialties Board of Directors |
Dr. Calvin H. Knowlton |
67 |
Chairman and CEO, CareKinesis, Inc.*;Member of the Board and Executive Committee, Coriell Institute for Medical Research; Chair, Board of Coriell Life Sciences, Inc.; Board Chair, Evergreens Continuing Care Retirement Community Board of Trustees; Board Chair, Founding Member, The Board of the Cooper Medical School of Rowan University; Member, APha Pharmacogenomics Task Force and national Pharmacogenomics Advisory Group |
Dr. Orsula V. Knowlton |
49 |
President and Director, CareKinesis, Inc. *;Board of Trustees and Chair of Quality Committee Samaritan Hospice; Member, Board of Trustees for the West Jersey Chamber Music Society |
A Gordon Tunstall |
73 |
Director, CareKinesis*;Founder, Tunstall Consulting |
*CareKinesis is a wholly owned subsidiary of Tabula Rasa Healthcare.
Noteworthy Control
Name |
Shares of common stock owned |
% of total common shares |
Originate Growth Fund #1 Q, L.P. and its affiliates |
2,794,932 |
16.3 percent
|
Glenn Bressner |
2,794,932 |
16.3% |
Dr. Calvin H. Knowlton
|
2,017,803 |
11.8% |
Dr. Orsula V. Knowlton |
2,017,803 |
11.8% |
Radius Venture Partners III QP, L.P. and its affiliates |
1,842,301
|
10.8% |
Daniel Lubin |
1,842,407 |
10.8% |
Emerald Stage 2 Ventures L.P. |
960,407 |
5.6% |
Bruce Luehrs
|
960,407 |
5.6% |
[All information for NJ Tech Corner was taken from the company’s annual reports and proxy statements and other company sources, with the exception of the company’s stock price and valuation.]